PLRX FY 2021 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-81.9% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$98M-1288.1% margin

Net Income

-$97M-1284.5% margin

EPS (Diluted)

$-2.71

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$77M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$221M

Total Liabilities

$22M

Stockholders' Equity

$199M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$42M	-81.9%
Gross Profit	$8M	$42M	-81.9%
Operating Income	-$98M	-$42M	-134.2%
Net Income	-$97M	-$42M	-134.2%